Cite
Low dose TamOxifen and LifestylE changes for bReast cANcer prevention (TOLERANT study): Study protocol of a randomized phase II biomarker trial in women at increased risk for breast cancer.
MLA
Guerrieri-Gonzaga, Aliana, et al. “Low Dose TamOxifen and LifestylE Changes for BReast CANcer Prevention (TOLERANT Study): Study Protocol of a Randomized Phase II Biomarker Trial in Women at Increased Risk for Breast Cancer.” PloS One, vol. 19, no. 9, Sept. 2024, p. e0309511. EBSCOhost, https://doi.org/10.1371/journal.pone.0309511.
APA
Guerrieri-Gonzaga, A., Serrano, D., Gnagnarella, P., Johansson, H., Zovato, S., Nardi, M., Pensabene, M., Buccolo, S., DeCensi, A., Briata, I. M., Pistelli, L., Sansone, C., Mannucci, S., Aristarco, V., Macis, D., Lazzeroni, M., Aurilio, G., Accornero, C. A., Gandini, S., & Bonanni, B. (2024). Low dose TamOxifen and LifestylE changes for bReast cANcer prevention (TOLERANT study): Study protocol of a randomized phase II biomarker trial in women at increased risk for breast cancer. PloS One, 19(9), e0309511. https://doi.org/10.1371/journal.pone.0309511
Chicago
Guerrieri-Gonzaga, Aliana, Davide Serrano, Patrizia Gnagnarella, Harriet Johansson, Stefania Zovato, Mariateresa Nardi, Matilde Pensabene, et al. 2024. “Low Dose TamOxifen and LifestylE Changes for BReast CANcer Prevention (TOLERANT Study): Study Protocol of a Randomized Phase II Biomarker Trial in Women at Increased Risk for Breast Cancer.” PloS One 19 (9): e0309511. doi:10.1371/journal.pone.0309511.